Propionibacterium acnes

Open Access

Clinical Therapeutics
Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris
Sarecycline is the first narrow-spectrum tetracycline-class antibiotic being developed for acne treatment. In addition to exhibiting activity against important skin/soft tissue pathogens, sarecycline exhibits targeted antibacterial activity against clinical isolates of Cutibacterium acnes.

George Zhanel, Ian Critchley, Lynn-Yao Lin, Nancy Alvandi
Susceptibility
In Vitro Activities of Pexiganan and 10 Comparator Antimicrobials against 502 Anaerobic Isolates Recovered from Skin and Skin Structure Infections
Ellie J. C. Goldstein, Diane M. Citron, Kerin L. Tyrrell, Eliza S. Leoncio
Experimental Therapeutics
Activity of Electrical Current in Experimental Propionibacterium acnes Foreign-Body Osteomyelitis
Suzannah M. Schmidt-Malan, Cassandra L. Brinkman, Kerryl E. Greenwood-Quaintance, Melissa J. Karau, Jayawant N. Mandrekar, Robin Patel

Main menu